Lymphoseek: Clinical Trials

4 trials of Lymphoseek, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Terminated 2

Follow Lymphoseek: new trials by email Literature Review of Lymphoseek trials Research Report on Lymphoseek

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
TC99m-tilmanocept - Rheumatoid Arthritis
Phase 3TerminatedNavidea Biopharmaceuticals1692022-03-022025-01-23
Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
Lymphoseek - Breast Cancer, Melanoma
Phase 3CompletedNavidea Biopharmaceuticals1632010-06-012013-06-17
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Lymphoseek - Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 3TerminatedNavidea Biopharmaceuticals1012009-05-012014-08-08
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
Lymphoseek - Breast Cancer, Melanoma
Phase 3CompletedNavidea Biopharmaceuticals1862008-04-012013-06-17

Conditions studied

Breast Neoplasms (2)  ·  Melanoma (2)  ·  Arthritis, Rheumatoid (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Navidea Biopharmaceuticals (4)

Countries

United States (4)  ·  Israel (1)

Top investigators

Bonnie C Abbruzzese, MS RD (1)  ·  Michael Blue, MD (1)  ·  Richard Orahood, M.D. (1)  ·  Simon A Blackburn (1)

Results publications

PMID 23054107, PMID 23504141, PMID 24051744, PMID 25670018